The effect of protease inhibitors, leupeptin and pepstatin A, on the metabolism of acetylated low density lipoprotein (acetyl-LDL) was investigated in cultured rat peritoneal macrophages and compared with that of chloroquine.
Acetyl-LDL accumulates in macrophages via scavenger receptors, where it is degraded by lysosomes (1, 2) . Apolipoproteins are digested by lysosomal proteases, while cholesteryl esters in the lipoprotein are hydrolyzed by lysosomal acid lipase (1, 2) . As for the proteases, the results of in vitro studies suggest that thiol proteases and cathepsins participate in the degradation of apolipoproteins, using methods such as sonicated macrophages (3), subcellular fractions of macrophages (4) , or a direct incubation of lipoprotein with cathepsins (5). However, their roles in cell culture systems have been obscure. Therefore, we examined the effect of lysosomal protease inhibitors on the metabolism of acetyl-LDL in cultured rat peritoneal macrophages.
Materials and Methods

Materials
Leupeptin and pepstatin A were purchased from Peptide Institute, Inc. (Osaka, Japan). Chloroquine diphosphate, HBSS, and bovine serum albumin (BSA) were purchased from Sigma Chemical Co. (St. Louis, MO). Eagle's minimum essential medium (EMEM) was purchased from Nissui Seiyaku Co., Ltd. (Tokyo, Japan). Fatal calf serum (FCS) was purchased from Gibco (Grand Island, NY cathepsin D (14-16). Our finding indicates that both the thiol proteases and cathepsin D participate in the intracellular degradation of lipoproteins, which is consistent with the in vitro result of Rankin et al. who investigated the effect of proteases on LDL using whole-cell sonicates of macrophages (3). The actual concentration of protease inhibitors attained in lysosomes was not measured in this experiment.
In our previous work, leupeptin was easily incorporated into thyroid lysosomes within 2 hours in the organ culture of rat thyroid glands (15, 16). Aulinskas et al. reported the inhibition of LDL degradation by the addition of 100 jug/m1 of leupeptin to cultured smooth muscle cell media (17). On the other hand, pepstatin is not readily introduced into lysosomes (14-16). Therefore, the role of cathepsins in the degradation of lipoproteins has been investigated by in vitro methods using such as sonicated macrophages (3), subcellular fraction of macrophages (4), or cathepsin itself (5). In this experiment, pepstatin in the media inhibited the degradation of acetyl-LDL in the cell culture system as well as leupeptin did. As for the chloroquine, it was reported that chloroquine inhibited both the degradation of apolipoprotein and the incorporation of oleic acid into cellular cholesteryl-oleate in macrophages incubated with acetyl-LDL (1, 11) .
In addition to those phenomena, in our study, chloroquine caused a prominent increase in cholesterol contents in macrophages.
Such changes in cholesterol metabolism seem to be attributed to the suppression of the release of free cholesterol from lysosomes owing to the inhibited hydroxylation of cholesterol esters contained in lipoproteins, because this novel lysosomotrophic agent is considered to inhibit both acid proteases and acid It is suggested that the inhibition of proteases by itself could, at least in part, suppress the release of cholesterol from lipoprotein. These changes by protease inhibitors, however, seemed to be less effective than those induced by chloroquine. Lipoprotein is complex of phospholipids, and free and esterified cholesterols. Therefore, cooperation of various hydrolases seems to be necessary for lysosomal liberation of cholesterols from lipoproteins. It is concluded that leupeptin and pepstatin A inhibited the degradation of acetyl-LDL in cultured macrophages. The inhibition of the degradation of acetyl-LDL by leupeptin and pepstatin indicates the importance of thiol proteases and cathepsin D in the lysosomal degradation of lipoproteins. Since the protease inhibitors also suppressed [3H] oleate incorporation and increased the cellular cholesterol content, the breakdown of apolipoproteins seems to be necessary for the complete release of free cholesterol from lipoproteins.
